Fennec Pharmaceuticals In... (FENC)
NASDAQ: FENC
· Real-Time Price · USD
8.39
-0.14 (-1.64%)
At close: Aug 15, 2025, 3:59 PM
8.36
-0.36%
After-hours: Aug 15, 2025, 04:10 PM EDT
Fennec Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.17M | -1.99M | -5.68M | -5.55M | 12.78M | -2.76M | -1.84M | -5.44M | -6.05M | -6.86M | -8.09M | -5.07M | -3.7M | -4.43M | -4.18M | -4M | -4.73M |
Depreciation & Amortization | 26K | 26K | 89K | 26K | 723K | 242K | n/a | -73K | 52K | 132K | 60.4K | 14K | 6K | 8K | 8K | n/a | n/a |
Stock-Based Compensation | 798K | 1.12M | 1.82M | 925K | 1.19M | 857K | 865K | 2.54M | 1.09M | 857K | 1.89M | 1.01M | 399K | 910K | 917K | 1.33M | 596K |
Other Working Capital | n/a | -13K | -15.46M | -1.15M | 23.7M | 765.64K | 612.18K | 107K | -77K | 1.33M | 311K | 104K | -138K | 213K | -136K | -4K | -211K |
Other Non-Cash Items | n/a | -639K | 21.32M | 4.37M | 429K | 89.78K | 74.24K | 73K | 50K | 26K | 125K | 37K | 132K | 436K | 8K | 84K | -182K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -73K | n/a | 73K | n/a | n/a | -60.4K | n/a | -6K | -8K | -47K | n/a | n/a |
Change in Working Capital | n/a | n/a | -19.75M | -4.01M | 23.76M | -3.17M | -1.83M | -1.12M | -716K | -930K | 1.1M | 623K | 309K | -164K | 341K | -1.83M | 726K |
Operating Cash Flow | -4.32M | -1.47M | -2.21M | -8.04M | 39.05M | -4.97M | -2.73M | -3.95M | -5.58M | -6.8M | -5.01M | -3.39M | -2.86M | -3.25M | -2.96M | -4.43M | -3.59M |
Capital Expenditures | n/a | n/a | 3.37 | -3.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 3.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 5.09M | n/a | n/a | n/a | -65K | 20M | n/a | n/a | n/a | n/a | 5M | n/a |
Common Stock Repurchased | n/a | n/a | 19K | n/a | -19K | -17K | -14K | -27K | -20K | -28K | -166K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 359K | -12.21M | -528K | -102.19K | -1.13M | -17.44K | -13.85K | 514K | 193K | 889K | -153K | 46K | 15K | 10K | n/a | -32K | n/a |
Financial Cash Flow | 359K | -12.21M | -528K | 246.87K | -1.13M | 5.84M | 198.81K | 514K | 193K | 824K | 19.85M | 46K | 15K | 10K | 29.72K | 4.97M | n/a |
Net Cash Flow | -3.96M | -13.69M | -2.73M | -8.08M | 37.91M | 861.54K | -2.59M | -3.43M | -5.38M | -5.98M | 14.84M | -3.34M | -2.84M | -3.23M | -2.96M | 542K | -3.59M |
Free Cash Flow | -4.32M | -1.47M | -2.21M | -8.04M | 38.87M | -4.97M | -2.73M | -3.95M | -5.58M | -6.8M | -5.01M | -3.39M | -2.86M | -3.25M | -2.96M | -4.43M | -3.59M |